Quality Assured
Supplied across India with dependable dispatch.
Montevot
Montelukast Sodium & Levocetirizine HCl Tablets
Montevot combines a leukotriene receptor antagonist (Montelukast) with a 2nd generation antihistamine (Levocetirizine) to provide comprehensive dual control over the early and late allergic cascade.
Product Specifications
| Composition | Each film coated tablet contains: Montelukast Sodium IP eq. to Montelukast 10 mg + Levocetirizine Dihydrochloride IP 5 mg |
| Pack Size | 10 x 10 Tablets (Alu-Alu) |
| Dosage Form | Tablet |
| Storage | Store in a cool, dry place below 30°C. Protect from light. |
Therapeutic Indications
Key Formulation USPs
- Synergistic dual action blocking both histamine and leukotrienes
- Controls daytime and nighttime asthma & rhinitis symptoms
- Significantly reduces frequency of acute asthma flares
- Convenient once-daily evening dosing
- Premium moisture-resistant Alu-Alu packaging
Frequently Asked Questions About Montevot
Essential product details, active salt composition, dosage specifications, and PCD franchise distribution queries answered.
Montevot is a pharmaceutical tablet containing Montelukast Sodium & Levocetirizine HCl Tablets. It is manufactured by Medizons International Pvt. Ltd. and primarily indicated for Asthma prophylaxis with concomitant allergic rhinitis, Exercise-induced bronchoconstriction, Persistent seasonal and perennial allergic rhinitis, Chronic allergic bronchitis.
Related Medicines
TabletRespiratory
TabletRespiratory
SyrupRespiratory